An implanted antenna can support cancer surveillance when a disease-related change produces a reproducible measurement that can be distinguished from relevant benign changes and interpreted within a defined clinical pathway. This critical review connects cancer biomarkers, local physiological changes, biosensor mechanisms, and in-body RF interfaces across major tumour sites, with particular attention to oral, head and neck, and lung cancer. Three approaches are distinguished: antennas that sense tissue dielectric properties, chemically functionalized antenna immunosensors, and separate cancer sensors coupled to implanted radio telemetry. The unresolved problem is durable, site- and endpoint-specific surveillance under realistic sampling, inflammatory, bio-interface, and wireless constraints. Comparative evidence tables identify measured specimens, demonstrated endpoints, candidate sensor–antenna combinations, and decisive missing experiments. A compact quantitative framework links target access, binding, RF observability, confounder control, read availability, and false-alert burden. A gated development workflow, illustrated using a published CEA antenna, converts these constraints into testable research requirements. The outcome is a research roadmap for clinically interpretable local warnings.

Implantable Antenna–Biosensor Systems for Cancer Surveillance: Evidence, Biological Interfaces, and a Translational Design Framework / Singhwal, S.S.. - In: ELECTRONICS. - ISSN 2079-9292. - 15:22(2026). [10.3390/electronics15225395]

Implantable Antenna–Biosensor Systems for Cancer Surveillance: Evidence, Biological Interfaces, and a Translational Design Framework

Singhwal, Sumer Singh
2026

Abstract

An implanted antenna can support cancer surveillance when a disease-related change produces a reproducible measurement that can be distinguished from relevant benign changes and interpreted within a defined clinical pathway. This critical review connects cancer biomarkers, local physiological changes, biosensor mechanisms, and in-body RF interfaces across major tumour sites, with particular attention to oral, head and neck, and lung cancer. Three approaches are distinguished: antennas that sense tissue dielectric properties, chemically functionalized antenna immunosensors, and separate cancer sensors coupled to implanted radio telemetry. The unresolved problem is durable, site- and endpoint-specific surveillance under realistic sampling, inflammatory, bio-interface, and wireless constraints. Comparative evidence tables identify measured specimens, demonstrated endpoints, candidate sensor–antenna combinations, and decisive missing experiments. A compact quantitative framework links target access, binding, RF observability, confounder control, read availability, and false-alert burden. A gated development workflow, illustrated using a published CEA antenna, converts these constraints into testable research requirements. The outcome is a research roadmap for clinically interpretable local warnings.
2026
File in questo prodotto:
File Dimensione Formato  
electronics-15-05395.pdf

accesso aperto

Tipologia: 2a Post-print versione editoriale / Version of Record
Licenza: Creative commons
Dimensione 5.38 MB
Formato Adobe PDF
5.38 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11583/3018155